| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9017434 | Pulmonary Pharmacology & Therapeutics | 2005 | 7 Pages |
Abstract
We conclude that oral NAC 600Â mg b.i.d. for 2 months rapidly reduces the oxidant burden in airways of stable COPD patients.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Fernando De Benedetto, Antonio Aceto, Beatrice Dragani, Antonella Spacone, Stefano Formisano, Riccardo Pela, Claudio F. Donner, Claudio M. Sanguinetti,